Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s):  MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.


CSE:MYCO - Post by User

Post by sledheadon Oct 05, 2018 12:42pm
148 Views
Post# 28752982

Good read.

Good read.VANCOUVER, British Columbia, Oct. 04, 2018 (GLOBE NEWSWIRE) -- New Age Farm Inc. (CSE:NF) (OTC:NWGFF) (FSE:ONF) (“New Age Farm” or the “Company”) is pleased to announce that Fresh Water, the flagship product of the Company’s newly acquired wholly owned subsidiary Drink Fresh Water LLC, can now be found in retail stores in 35 states across the nation.  Fresh Water has continued to rapidly expand its footprint since inception.

Joshua Bartch, New Age Farm’s Chief Executive Officer, stated: “We couldn’t be more pleased with the rapid growth of Fresh Water.  Not only does the company’s footprint span more than 50% of the nation but we are continuing to see rapid growth and an amazing retention rate.  Additionally, we are currently working to drop the product in the established distribution through We Are Kured, LLC as well as evaluate new products to add to the line. We are very excited about the future of Fresh Water and will be updating our shareholders on more advancements in the near future.”

If stocks like IGC and NBEV can go on substantial runs, adding well over $100 million in market cap merely on plans to enter the CBD market and even stocks like DTEA and PTIE can temporarily add $25 million market cap or more on rumors before pulling back once those rumors are squashed, how much can NeutriSci with its minuscule $15 million U.S. market cap and New Age Farm with its very small $29 million U.S. market cap move with CBD products actually in market and distribution in place? We expect these stocks to go on monster runs, because investors who want to chase cheap CBD players will eventually come looking for something with substance after being burned on stocks like PTIE and DTEA and turned off by the valuations of the great planners like NBEV and IGC.

Disclosure: We are long NU.V and NF.CN
Bullboard Posts